Nuveen Asset Management LLC Has $5.56 Million Holdings in Sotera Health (NASDAQ:SHC)

Nuveen Asset Management LLC lessened its holdings in shares of Sotera Health (NASDAQ:SHC - Free Report) by 7.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 406,655 shares of the company's stock after selling 30,861 shares during the period. Nuveen Asset Management LLC owned 0.14% of Sotera Health worth $5,563,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the business. Irenic Capital Management LP boosted its stake in Sotera Health by 4.3% during the 4th quarter. Irenic Capital Management LP now owns 2,909,163 shares of the company's stock valued at $39,797,000 after purchasing an additional 120,832 shares during the period. D. E. Shaw & Co. Inc. boosted its stake in Sotera Health by 140.8% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 2,624,750 shares of the company's stock valued at $35,907,000 after purchasing an additional 1,534,666 shares during the period. Corton Capital Inc. acquired a new position in Sotera Health during the 4th quarter valued at about $139,000. Brevan Howard Capital Management LP boosted its stake in Sotera Health by 127.0% during the 4th quarter. Brevan Howard Capital Management LP now owns 79,156 shares of the company's stock valued at $1,083,000 after purchasing an additional 44,280 shares during the period. Finally, Bridgefront Capital LLC acquired a new position in Sotera Health during the 4th quarter valued at about $185,000. Institutional investors own 91.03% of the company's stock.

Sotera Health Price Performance

SHC stock traded up $0.08 on Wednesday, hitting $12.36. 1,202,293 shares of the company's stock traded hands, compared to its average volume of 1,200,266. Sotera Health has a 1-year low of $9.53 and a 1-year high of $17.08. The stock has a market cap of $3.51 billion, a price-to-earnings ratio of 49.44 and a beta of 1.87. The stock has a fifty day moving average of $11.71 and a 200-day moving average of $12.57. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.12 by $0.02. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The business had revenue of $254.52 million for the quarter, compared to analyst estimates of $245.56 million. During the same quarter in the previous year, the business earned $0.13 earnings per share. The firm's revenue was up 2.6% compared to the same quarter last year. On average, analysts forecast that Sotera Health will post 0.61 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Barclays reduced their target price on shares of Sotera Health from $16.00 to $12.00 and set an "overweight" rating for the company in a research note on Thursday, April 10th. Piper Sandler reduced their target price on shares of Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a research note on Wednesday, April 23rd. Finally, The Goldman Sachs Group raised shares of Sotera Health from a "neutral" rating to a "buy" rating and boosted their target price for the company from $14.00 to $17.00 in a research note on Monday, May 5th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $15.80.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.